

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of skeletal muscle contraction (GO:0014819) | 9.60468456 |
| 2 | skeletal muscle tissue regeneration (GO:0043403) | 9.47222984 |
| 3 | muscle filament sliding (GO:0030049) | 9.23383061 |
| 4 | actin-myosin filament sliding (GO:0033275) | 9.23383061 |
| 5 | response to muscle activity (GO:0014850) | 8.27200193 |
| 6 | negative regulation of skeletal muscle tissue development (GO:0048642) | 8.15682188 |
| 7 | actin-mediated cell contraction (GO:0070252) | 7.50682070 |
| 8 | cellular response to dexamethasone stimulus (GO:0071549) | 6.76013378 |
| 9 | response to dexamethasone (GO:0071548) | 6.22796419 |
| 10 | response to activity (GO:0014823) | 5.78018353 |
| 11 | protein K6-linked ubiquitination (GO:0085020) | 5.38263422 |
| 12 | actin filament-based movement (GO:0030048) | 5.11569439 |
| 13 | striated muscle adaptation (GO:0014888) | 4.96411070 |
| 14 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 4.73901180 |
| 15 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.64954686 |
| 16 | ribosomal small subunit assembly (GO:0000028) | 4.50577136 |
| 17 | regulation of muscle hypertrophy (GO:0014743) | 4.47441302 |
| 18 | viral transcription (GO:0019083) | 4.37021865 |
| 19 | negative regulation of organelle assembly (GO:1902116) | 4.33723663 |
| 20 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 4.30556209 |
| 21 | protein trimerization (GO:0070206) | 4.25353871 |
| 22 | dosage compensation (GO:0007549) | 4.18926536 |
| 23 | translational termination (GO:0006415) | 4.12628153 |
| 24 | protein polyglutamylation (GO:0018095) | 4.04808406 |
| 25 | myotube cell development (GO:0014904) | 4.03924922 |
| 26 | response to testosterone (GO:0033574) | 4.00452866 |
| 27 | response to electrical stimulus (GO:0051602) | 3.98881259 |
| 28 | translational elongation (GO:0006414) | 3.95704890 |
| 29 | muscle adaptation (GO:0043500) | 3.89059307 |
| 30 | regulation of DNA methylation (GO:0044030) | 3.83759292 |
| 31 | skeletal muscle contraction (GO:0003009) | 3.81059827 |
| 32 | ribosomal small subunit biogenesis (GO:0042274) | 3.75842771 |
| 33 | negative regulation of striated muscle tissue development (GO:0045843) | 3.74624781 |
| 34 | negative regulation of muscle tissue development (GO:1901862) | 3.73308818 |
| 35 | muscle organ development (GO:0007517) | 3.68888646 |
| 36 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.63756592 |
| 37 | muscle structure development (GO:0061061) | 3.62104971 |
| 38 | cell proliferation in forebrain (GO:0021846) | 3.60699051 |
| 39 | negative regulation of muscle organ development (GO:0048635) | 3.47668013 |
| 40 | regulation of centriole replication (GO:0046599) | 3.46178915 |
| 41 | skeletal muscle fiber development (GO:0048741) | 3.42792107 |
| 42 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.41625581 |
| 43 | cellular response to glucocorticoid stimulus (GO:0071385) | 3.40493017 |
| 44 | protein neddylation (GO:0045116) | 3.40042446 |
| 45 | tissue regeneration (GO:0042246) | 3.36756909 |
| 46 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.32126899 |
| 47 | positive regulation of histone H3-K4 methylation (GO:0051571) | 3.29606928 |
| 48 | regulation of gene expression by genetic imprinting (GO:0006349) | 3.27544090 |
| 49 | protein targeting to ER (GO:0045047) | 3.26383906 |
| 50 | regulation of relaxation of muscle (GO:1901077) | 3.25917300 |
| 51 | cotranslational protein targeting to membrane (GO:0006613) | 3.23785840 |
| 52 | dendritic spine morphogenesis (GO:0060997) | 3.20270749 |
| 53 | cellular response to corticosteroid stimulus (GO:0071384) | 3.13294451 |
| 54 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.11955376 |
| 55 | dentate gyrus development (GO:0021542) | 3.11903332 |
| 56 | cellular protein complex disassembly (GO:0043624) | 3.07060336 |
| 57 | protein localization to endoplasmic reticulum (GO:0070972) | 3.06931810 |
| 58 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.05485403 |
| 59 | viral life cycle (GO:0019058) | 3.02959042 |
| 60 | cellular response to ketone (GO:1901655) | 3.02620185 |
| 61 | myoblast migration (GO:0051451) | 2.98437112 |
| 62 | muscle system process (GO:0003012) | 2.97773808 |
| 63 | heparin metabolic process (GO:0030202) | 2.96966530 |
| 64 | heparin biosynthetic process (GO:0030210) | 2.96966530 |
| 65 | muscle contraction (GO:0006936) | 2.88957337 |
| 66 | negative regulation of histone acetylation (GO:0035067) | 2.88708709 |
| 67 | genetic imprinting (GO:0071514) | 2.87025531 |
| 68 | response to inactivity (GO:0014854) | 2.73652480 |
| 69 | translational initiation (GO:0006413) | 2.72735554 |
| 70 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.72473676 |
| 71 | protein complex disassembly (GO:0043241) | 2.70638058 |
| 72 | negative regulation of fatty acid metabolic process (GO:0045922) | 2.70033458 |
| 73 | regulation of histone H3-K9 methylation (GO:0051570) | 2.68949783 |
| 74 | somite development (GO:0061053) | 2.67345118 |
| 75 | maturation of SSU-rRNA (GO:0030490) | 2.65602354 |
| 76 | radial glial cell differentiation (GO:0060019) | 2.65440852 |
| 77 | mesonephros development (GO:0001823) | 2.62506460 |
| 78 | viral genome replication (GO:0019079) | 2.59113610 |
| 79 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.57597775 |
| 80 | macromolecular complex disassembly (GO:0032984) | 2.57421317 |
| 81 | pattern specification involved in kidney development (GO:0061004) | 2.52452344 |
| 82 | negative regulation of peptidyl-lysine acetylation (GO:2000757) | 2.51847711 |
| 83 | heart field specification (GO:0003128) | 2.49378618 |
| 84 | secondary heart field specification (GO:0003139) | 2.49378618 |
| 85 | negative regulation of histone methylation (GO:0031061) | 2.48966729 |
| 86 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.47745449 |
| 87 | calcium ion import (GO:0070509) | 2.47346792 |
| 88 | nephron epithelium morphogenesis (GO:0072088) | 2.43196894 |
| 89 | nephron tubule morphogenesis (GO:0072078) | 2.43196894 |
| 90 | regulation of germinal center formation (GO:0002634) | 2.42435537 |
| 91 | cartilage morphogenesis (GO:0060536) | 2.40311944 |
| 92 | muscle fiber development (GO:0048747) | 2.38347595 |
| 93 | middle ear morphogenesis (GO:0042474) | 2.37150908 |
| 94 | lymphangiogenesis (GO:0001946) | 2.36791791 |
| 95 | positive regulation of gastrulation (GO:2000543) | 2.36714364 |
| 96 | response to gravity (GO:0009629) | 14.9014935 |
| 97 | skeletal muscle adaptation (GO:0043501) | 12.0224802 |
| 98 | striated muscle atrophy (GO:0014891) | 11.7976573 |
| 99 | muscle atrophy (GO:0014889) | 10.6080633 |
| 100 | negative regulation of muscle hypertrophy (GO:0014741) | 10.5090271 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 8.14997184 |
| 2 | VDR_22108803_ChIP-Seq_LS180_Human | 8.00375671 |
| 3 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 5.25312612 |
| 4 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 5.02889068 |
| 5 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 4.60778396 |
| 6 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.84524925 |
| 7 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.44919470 |
| 8 | FUS_26573619_Chip-Seq_HEK293_Human | 2.80930849 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.51692224 |
| 10 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.49353830 |
| 11 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.41681887 |
| 12 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.18874708 |
| 13 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.17755150 |
| 14 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.00914645 |
| 15 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.93573123 |
| 16 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.92441268 |
| 17 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.82378310 |
| 18 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.82004891 |
| 19 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.76162242 |
| 20 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.67633281 |
| 21 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.67511112 |
| 22 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.62875742 |
| 23 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.60299446 |
| 24 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.59685325 |
| 25 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.59014727 |
| 26 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.58013306 |
| 27 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.55482412 |
| 28 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.54908759 |
| 29 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.54008693 |
| 30 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.51303239 |
| 31 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.49623872 |
| 32 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.47391231 |
| 33 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.45088435 |
| 34 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.44172585 |
| 35 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.44172585 |
| 36 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.43378038 |
| 37 | RXR_22108803_ChIP-Seq_LS180_Human | 1.39606045 |
| 38 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.38441924 |
| 39 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.38196872 |
| 40 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.36523675 |
| 41 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.32349932 |
| 42 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.30803620 |
| 43 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.30803620 |
| 44 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.30803620 |
| 45 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.28683684 |
| 46 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.26256264 |
| 47 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.25861492 |
| 48 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.21142968 |
| 49 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.18674324 |
| 50 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.18597766 |
| 51 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.17963082 |
| 52 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.17248186 |
| 53 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.16743879 |
| 54 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.15523072 |
| 55 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.15360196 |
| 56 | P300_19829295_ChIP-Seq_ESCs_Human | 1.13877385 |
| 57 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.09022658 |
| 58 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.07140618 |
| 59 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.06278789 |
| 60 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.05907546 |
| 61 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.05805778 |
| 62 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.04587722 |
| 63 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.00076627 |
| 64 | MNX1_26342078_ChIP-Seq_MIN6-4N_Mouse | 1.00060018 |
| 65 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.98087293 |
| 66 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.97173358 |
| 67 | KDM2B_26808549_Chip-Seq_REH_Human | 0.97000306 |
| 68 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.94933030 |
| 69 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.94852367 |
| 70 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.93966612 |
| 71 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.92978607 |
| 72 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.92965583 |
| 73 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.91499633 |
| 74 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.90403169 |
| 75 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.89959763 |
| 76 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.89426047 |
| 77 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.88408864 |
| 78 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.87504689 |
| 79 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.86469060 |
| 80 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.86364801 |
| 81 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.85336322 |
| 82 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.82737989 |
| 83 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.82530030 |
| 84 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.78538873 |
| 85 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.78460744 |
| 86 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.77231384 |
| 87 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.77012203 |
| 88 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.76618454 |
| 89 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.75399760 |
| 90 | CBP_21632823_ChIP-Seq_H3396_Human | 0.74269554 |
| 91 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.74178108 |
| 92 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.72725416 |
| 93 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.72520235 |
| 94 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.72386224 |
| 95 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.71555925 |
| 96 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.71173132 |
| 97 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.69647551 |
| 98 | STAT3_23295773_ChIP-Seq_U87_Human | 0.69551678 |
| 99 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.69174776 |
| 100 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.69174776 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 5.21249089 |
| 2 | MP0000747_muscle_weakness | 4.98583590 |
| 3 | MP0002089_abnormal_postnatal_growth/wei | 4.23128305 |
| 4 | MP0003705_abnormal_hypodermis_morpholog | 3.65203333 |
| 5 | MP0004036_abnormal_muscle_relaxation | 3.48058288 |
| 6 | MP0000749_muscle_degeneration | 3.14492451 |
| 7 | MP0002269_muscular_atrophy | 3.02401547 |
| 8 | MP0000759_abnormal_skeletal_muscle | 2.96206718 |
| 9 | MP0005083_abnormal_biliary_tract | 2.77443191 |
| 10 | MP0000566_synostosis | 2.61826842 |
| 11 | MP0002106_abnormal_muscle_physiology | 2.57307329 |
| 12 | MP0009379_abnormal_foot_pigmentation | 2.53848265 |
| 13 | MP0005620_abnormal_muscle_contractility | 2.35944897 |
| 14 | MP0002108_abnormal_muscle_morphology | 2.32171633 |
| 15 | MP0003646_muscle_fatigue | 2.23189965 |
| 16 | MP0004087_abnormal_muscle_fiber | 2.20656867 |
| 17 | MP0006292_abnormal_olfactory_placode | 2.19901526 |
| 18 | MP0010030_abnormal_orbit_morphology | 2.19321324 |
| 19 | MP0003959_abnormal_lean_body | 2.10540920 |
| 20 | MP0002138_abnormal_hepatobiliary_system | 2.10299638 |
| 21 | MP0005369_muscle_phenotype | 1.96627846 |
| 22 | MP0000750_abnormal_muscle_regeneration | 1.91617598 |
| 23 | MP0001968_abnormal_touch/_nociception | 1.85827092 |
| 24 | MP0000372_irregular_coat_pigmentation | 1.81772202 |
| 25 | MP0008789_abnormal_olfactory_epithelium | 1.81155112 |
| 26 | MP0003937_abnormal_limbs/digits/tail_de | 1.74143957 |
| 27 | MP0000751_myopathy | 1.71018497 |
| 28 | MP0001879_abnormal_lymphatic_vessel | 1.61706462 |
| 29 | MP0000049_abnormal_middle_ear | 1.61546797 |
| 30 | MP0002736_abnormal_nociception_after | 1.57375547 |
| 31 | MP0009250_abnormal_appendicular_skeleto | 1.49285050 |
| 32 | MP0000733_abnormal_muscle_development | 1.40798746 |
| 33 | MP0002095_abnormal_skin_pigmentation | 1.40219415 |
| 34 | MP0004142_abnormal_muscle_tone | 1.39995611 |
| 35 | MP0002638_abnormal_pupillary_reflex | 1.39086676 |
| 36 | MP0002277_abnormal_respiratory_mucosa | 1.38480432 |
| 37 | MP0003880_abnormal_central_pattern | 1.33483962 |
| 38 | MP0003938_abnormal_ear_development | 1.28870178 |
| 39 | MP0003123_paternal_imprinting | 1.28067179 |
| 40 | MP0000427_abnormal_hair_cycle | 1.26567923 |
| 41 | MP0004885_abnormal_endolymph | 1.26114876 |
| 42 | MP0002653_abnormal_ependyma_morphology | 1.25895235 |
| 43 | MP0004134_abnormal_chest_morphology | 1.23371684 |
| 44 | MP0002837_dystrophic_cardiac_calcinosis | 1.20604801 |
| 45 | MP0002896_abnormal_bone_mineralization | 1.18053008 |
| 46 | MP0006072_abnormal_retinal_apoptosis | 1.17583867 |
| 47 | MP0004270_analgesia | 1.11808933 |
| 48 | MP0002160_abnormal_reproductive_system | 1.04019958 |
| 49 | MP0004043_abnormal_pH_regulation | 1.01103784 |
| 50 | MP0009780_abnormal_chondrocyte_physiolo | 0.98512230 |
| 51 | MP0003787_abnormal_imprinting | 0.97293626 |
| 52 | MP0004130_abnormal_muscle_cell | 0.94051039 |
| 53 | MP0001485_abnormal_pinna_reflex | 0.92674105 |
| 54 | MP0002184_abnormal_innervation | 0.91713109 |
| 55 | MP0005499_abnormal_olfactory_system | 0.91598256 |
| 56 | MP0005394_taste/olfaction_phenotype | 0.91598256 |
| 57 | MP0000778_abnormal_nervous_system | 0.89088658 |
| 58 | MP0004484_altered_response_of | 0.88600922 |
| 59 | MP0000631_abnormal_neuroendocrine_gland | 0.87133934 |
| 60 | MP0001293_anophthalmia | 0.86722093 |
| 61 | MP0002876_abnormal_thyroid_physiology | 0.85303483 |
| 62 | MP0003755_abnormal_palate_morphology | 0.84865832 |
| 63 | MP0003121_genomic_imprinting | 0.83452143 |
| 64 | MP0002109_abnormal_limb_morphology | 0.80026689 |
| 65 | MP0002272_abnormal_nervous_system | 0.76463581 |
| 66 | MP0003119_abnormal_digestive_system | 0.76078529 |
| 67 | MP0003136_yellow_coat_color | 0.75904708 |
| 68 | MP0001905_abnormal_dopamine_level | 0.75541945 |
| 69 | MP0003045_fibrosis | 0.75294706 |
| 70 | MP0003878_abnormal_ear_physiology | 0.73067365 |
| 71 | MP0005377_hearing/vestibular/ear_phenot | 0.73067365 |
| 72 | MP0000467_abnormal_esophagus_morphology | 0.72338659 |
| 73 | MP0004133_heterotaxia | 0.71267558 |
| 74 | MP0002733_abnormal_thermal_nociception | 0.70695610 |
| 75 | MP0002102_abnormal_ear_morphology | 0.68731796 |
| 76 | MP0002177_abnormal_outer_ear | 0.68298765 |
| 77 | MP0004084_abnormal_cardiac_muscle | 0.67903419 |
| 78 | MP0002282_abnormal_trachea_morphology | 0.67752578 |
| 79 | MP0003942_abnormal_urinary_system | 0.67287265 |
| 80 | MP0000762_abnormal_tongue_morphology | 0.65928379 |
| 81 | MP0002116_abnormal_craniofacial_bone | 0.65663093 |
| 82 | MP0002114_abnormal_axial_skeleton | 0.65553905 |
| 83 | MP0005389_reproductive_system_phenotype | 0.64365231 |
| 84 | MP0003936_abnormal_reproductive_system | 0.63911018 |
| 85 | MP0002233_abnormal_nose_morphology | 0.63747070 |
| 86 | MP0010368_abnormal_lymphatic_system | 0.63130732 |
| 87 | MP0008057_abnormal_DNA_replication | 0.62669558 |
| 88 | MP0003315_abnormal_perineum_morphology | 0.62240812 |
| 89 | MP0003950_abnormal_plasma_membrane | 0.61822105 |
| 90 | MP0002115_abnormal_skeleton_extremities | 0.60225995 |
| 91 | MP0002067_abnormal_sensory_capabilities | 0.59748294 |
| 92 | MP0002127_abnormal_cardiovascular_syste | 0.59705582 |
| 93 | MP0001486_abnormal_startle_reflex | 0.57759722 |
| 94 | MP0002928_abnormal_bile_duct | 0.57492579 |
| 95 | MP0002734_abnormal_mechanical_nocicepti | 0.57090026 |
| 96 | MP0005551_abnormal_eye_electrophysiolog | 0.55505170 |
| 97 | MP0009745_abnormal_behavioral_response | 0.55386915 |
| 98 | MP0002210_abnormal_sex_determination | 0.55313591 |
| 99 | MP0001963_abnormal_hearing_physiology | 0.54545460 |
| 100 | MP0008872_abnormal_physiological_respon | 0.53751724 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Palpebral edema (HP:0100540) | 8.94844908 |
| 2 | Distal arthrogryposis (HP:0005684) | 6.77318868 |
| 3 | Round ear (HP:0100830) | 6.42733915 |
| 4 | Mask-like facies (HP:0000298) | 6.29723284 |
| 5 | Exercise-induced myalgia (HP:0003738) | 6.25436586 |
| 6 | Nemaline bodies (HP:0003798) | 6.21811736 |
| 7 | Absent phalangeal crease (HP:0006109) | 5.77395998 |
| 8 | Calcaneovalgus deformity (HP:0001848) | 5.59523524 |
| 9 | Ulnar deviation of the wrist (HP:0003049) | 5.52787565 |
| 10 | Deformed tarsal bones (HP:0008119) | 5.07307050 |
| 11 | Muscle fiber inclusion bodies (HP:0100299) | 4.96529528 |
| 12 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.87128626 |
| 13 | Abnormal finger flexion creases (HP:0006143) | 4.83415327 |
| 14 | Hyperkalemia (HP:0002153) | 4.66998237 |
| 15 | Periorbital edema (HP:0100539) | 4.63733024 |
| 16 | Facial edema (HP:0000282) | 4.43532842 |
| 17 | Type 1 muscle fiber predominance (HP:0003803) | 4.06122678 |
| 18 | Myoglobinuria (HP:0002913) | 3.29920780 |
| 19 | Fibular aplasia (HP:0002990) | 3.27315914 |
| 20 | Myopathic facies (HP:0002058) | 3.11320938 |
| 21 | Reticulocytopenia (HP:0001896) | 3.06942224 |
| 22 | Down-sloping shoulders (HP:0200021) | 3.00666910 |
| 23 | Exercise-induced muscle cramps (HP:0003710) | 2.97141998 |
| 24 | Stenosis of the external auditory canal (HP:0000402) | 2.97010962 |
| 25 | Nonprogressive disorder (HP:0003680) | 2.94826519 |
| 26 | Myotonia (HP:0002486) | 2.93636391 |
| 27 | Microglossia (HP:0000171) | 2.93447487 |
| 28 | Abnormality of the calcaneus (HP:0008364) | 2.92180688 |
| 29 | 3-Methylglutaconic aciduria (HP:0003535) | 2.89608424 |
| 30 | Decreased circulating renin level (HP:0003351) | 2.82611872 |
| 31 | Abnormality of potassium homeostasis (HP:0011042) | 2.61841007 |
| 32 | Oligomenorrhea (HP:0000876) | 2.56359197 |
| 33 | Abnormality of the parietal bone (HP:0002696) | 2.50027067 |
| 34 | Difficulty running (HP:0009046) | 2.47653258 |
| 35 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.42137699 |
| 36 | Bell-shaped thorax (HP:0001591) | 2.34281465 |
| 37 | Increased connective tissue (HP:0009025) | 2.33692253 |
| 38 | Short 4th metacarpal (HP:0010044) | 2.30656169 |
| 39 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.30656169 |
| 40 | Maternal diabetes (HP:0009800) | 2.29815945 |
| 41 | Supernumerary ribs (HP:0005815) | 2.27826126 |
| 42 | Rhabdomyolysis (HP:0003201) | 2.25303530 |
| 43 | Neoplasm of the heart (HP:0100544) | 2.21387403 |
| 44 | Supernumerary bones of the axial skeleton (HP:0009144) | 2.20888554 |
| 45 | Abnormality of the 4th metacarpal (HP:0010012) | 2.16905242 |
| 46 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.15222397 |
| 47 | Hypoplastic iliac wings (HP:0002866) | 2.12899783 |
| 48 | Septo-optic dysplasia (HP:0100842) | 2.12258407 |
| 49 | Metatarsus adductus (HP:0001840) | 2.11822414 |
| 50 | Muscle stiffness (HP:0003552) | 2.09676023 |
| 51 | Mesomelia (HP:0003027) | 2.08754031 |
| 52 | Hyperphosphatemia (HP:0002905) | 2.04095298 |
| 53 | Hypoplastic ischia (HP:0003175) | 2.03341443 |
| 54 | Asplenia (HP:0001746) | 2.01173283 |
| 55 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.98666613 |
| 56 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.94518008 |
| 57 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.92493943 |
| 58 | 2-3 toe syndactyly (HP:0004691) | 1.89890041 |
| 59 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.89178847 |
| 60 | Absent thumb (HP:0009777) | 1.87132546 |
| 61 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 1.86131452 |
| 62 | Rectal prolapse (HP:0002035) | 1.84724336 |
| 63 | Macroorchidism (HP:0000053) | 1.81589662 |
| 64 | Malignant hyperthermia (HP:0002047) | 1.79372761 |
| 65 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.77722191 |
| 66 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.76752315 |
| 67 | Conjunctival hamartoma (HP:0100780) | 1.76484474 |
| 68 | Tarsal synostosis (HP:0008368) | 1.74099232 |
| 69 | Molar tooth sign on MRI (HP:0002419) | 1.73696425 |
| 70 | Abnormality of midbrain morphology (HP:0002418) | 1.73696425 |
| 71 | Type II lissencephaly (HP:0007260) | 1.73085714 |
| 72 | Hypoplasia of the ulna (HP:0003022) | 1.70964868 |
| 73 | Generalized muscle weakness (HP:0003324) | 1.70488171 |
| 74 | Paralysis (HP:0003470) | 1.70230005 |
| 75 | Acute necrotizing encephalopathy (HP:0006965) | 1.69792273 |
| 76 | Abnormality of the ischium (HP:0003174) | 1.69203095 |
| 77 | Colon cancer (HP:0003003) | 1.68895745 |
| 78 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.68085336 |
| 79 | Hypoplasia of the radius (HP:0002984) | 1.67141032 |
| 80 | Ectopic kidney (HP:0000086) | 1.64392151 |
| 81 | Hypokalemia (HP:0002900) | 1.63958305 |
| 82 | Forearm undergrowth (HP:0009821) | 1.63954646 |
| 83 | Abnormality of the peritoneum (HP:0002585) | 1.63695558 |
| 84 | Intellectual disability, moderate (HP:0002342) | 1.63657183 |
| 85 | Adrenal hypoplasia (HP:0000835) | 1.63458939 |
| 86 | Congenital stationary night blindness (HP:0007642) | 1.62076217 |
| 87 | Oligodactyly (hands) (HP:0001180) | 1.61898269 |
| 88 | Abnormality of the columella (HP:0009929) | 1.56819307 |
| 89 | Abnormal number of erythroid precursors (HP:0012131) | 1.56195168 |
| 90 | Synostosis involving bones of the feet (HP:0009140) | 1.55712371 |
| 91 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.55712371 |
| 92 | Poor eye contact (HP:0000817) | 1.52566169 |
| 93 | Abnormality of the renal collecting system (HP:0004742) | 1.52224529 |
| 94 | Delayed CNS myelination (HP:0002188) | 1.52223469 |
| 95 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.50551222 |
| 96 | Pendular nystagmus (HP:0012043) | 1.49916785 |
| 97 | Progressive macrocephaly (HP:0004481) | 1.48014180 |
| 98 | Oligodactyly (HP:0012165) | 1.46217235 |
| 99 | Abolished electroretinogram (ERG) (HP:0000550) | 1.45018272 |
| 100 | Metabolic acidosis (HP:0001942) | 1.42348653 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PHKG2 | 4.63035180 |
| 2 | PHKG1 | 4.63035180 |
| 3 | TIE1 | 4.19785188 |
| 4 | OBSCN | 3.83628335 |
| 5 | WNK4 | 3.79055692 |
| 6 | NME2 | 3.73637215 |
| 7 | MUSK | 2.90672103 |
| 8 | TYRO3 | 2.80882503 |
| 9 | STK16 | 2.63610685 |
| 10 | WNK1 | 2.62149801 |
| 11 | CAMKK2 | 2.48538448 |
| 12 | PIK3CA | 2.38168928 |
| 13 | LIMK1 | 2.13403037 |
| 14 | VRK2 | 1.91215628 |
| 15 | CAMK1D | 1.86370973 |
| 16 | STK39 | 1.82340040 |
| 17 | EPHB2 | 1.68401585 |
| 18 | TNIK | 1.59141497 |
| 19 | MAP3K12 | 1.58318332 |
| 20 | BCKDK | 1.54773917 |
| 21 | IRAK1 | 1.49487966 |
| 22 | MAPK13 | 1.48007872 |
| 23 | NUAK1 | 1.40807956 |
| 24 | CCNB1 | 1.36292484 |
| 25 | CASK | 1.35687317 |
| 26 | JAK3 | 1.30875317 |
| 27 | CHEK2 | 1.30472145 |
| 28 | MAP2K2 | 1.15587231 |
| 29 | CAMK1G | 1.14357984 |
| 30 | DYRK1B | 1.06296018 |
| 31 | AURKA | 1.04233907 |
| 32 | DYRK2 | 1.04041016 |
| 33 | ADRBK2 | 1.01023431 |
| 34 | PIK3CG | 0.97547922 |
| 35 | CAMK2G | 0.96724001 |
| 36 | PINK1 | 0.95402041 |
| 37 | MAPK7 | 0.95068510 |
| 38 | TXK | 0.91860840 |
| 39 | TEC | 0.90964236 |
| 40 | CAMK1 | 0.89351232 |
| 41 | LRRK2 | 0.85922299 |
| 42 | CAMKK1 | 0.84066422 |
| 43 | TAF1 | 0.78253907 |
| 44 | DYRK3 | 0.72857143 |
| 45 | CAMK4 | 0.72458473 |
| 46 | TESK1 | 0.71486582 |
| 47 | SGK494 | 0.70452504 |
| 48 | SGK223 | 0.70452504 |
| 49 | CDK4 | 0.67154384 |
| 50 | MST4 | 0.67111002 |
| 51 | BRAF | 0.62839932 |
| 52 | GRK1 | 0.61877123 |
| 53 | ARAF | 0.61453625 |
| 54 | MAP2K7 | 0.60239697 |
| 55 | MARK3 | 0.59240655 |
| 56 | CSNK1G1 | 0.58219592 |
| 57 | EPHA4 | 0.56604014 |
| 58 | TAOK3 | 0.54920854 |
| 59 | TESK2 | 0.53481497 |
| 60 | FRK | 0.52783627 |
| 61 | DDR2 | 0.51788073 |
| 62 | MAP3K11 | 0.51777677 |
| 63 | SGK2 | 0.50882588 |
| 64 | MAPK12 | 0.50379007 |
| 65 | ILK | 0.49713634 |
| 66 | EIF2AK2 | 0.48666427 |
| 67 | SGK1 | 0.45879559 |
| 68 | PRKG1 | 0.45655079 |
| 69 | MYLK | 0.44830406 |
| 70 | CSNK1G2 | 0.43791970 |
| 71 | PIM1 | 0.41076506 |
| 72 | PRKACA | 0.39501366 |
| 73 | OXSR1 | 0.39406561 |
| 74 | GRK6 | 0.39267048 |
| 75 | RPS6KA5 | 0.39086614 |
| 76 | NLK | 0.38713817 |
| 77 | CSNK1A1L | 0.38697439 |
| 78 | ATR | 0.38539603 |
| 79 | PDK2 | 0.37962343 |
| 80 | SGK3 | 0.37874623 |
| 81 | DAPK3 | 0.37327185 |
| 82 | DMPK | 0.37071326 |
| 83 | FGFR2 | 0.36981614 |
| 84 | ABL2 | 0.36916438 |
| 85 | RPS6KA6 | 0.36191293 |
| 86 | VRK1 | 0.33233463 |
| 87 | HIPK2 | 0.33160081 |
| 88 | CSNK1G3 | 0.32226450 |
| 89 | TLK1 | 0.30862659 |
| 90 | DAPK2 | 0.30321484 |
| 91 | PRKCE | 0.29364272 |
| 92 | AKT3 | 0.27494705 |
| 93 | PRKCG | 0.26866587 |
| 94 | RPS6KL1 | 0.26599227 |
| 95 | RPS6KC1 | 0.26599227 |
| 96 | ITK | 0.26224036 |
| 97 | IKBKE | 0.25733053 |
| 98 | PRKCQ | 0.25673358 |
| 99 | STK11 | 0.24216599 |
| 100 | RPS6KA3 | 0.21725641 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 5.92077429 |
| 2 | Tight junction_Homo sapiens_hsa04530 | 3.89896937 |
| 3 | Regulation of autophagy_Homo sapiens_hsa04140 | 2.81711048 |
| 4 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.67224139 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.52148341 |
| 6 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 2.37162730 |
| 7 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.09573586 |
| 8 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 2.05900005 |
| 9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.79628205 |
| 10 | Alzheimers disease_Homo sapiens_hsa05010 | 1.67363870 |
| 11 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.66857527 |
| 12 | Parkinsons disease_Homo sapiens_hsa05012 | 1.65616415 |
| 13 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.63569837 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 1.61766282 |
| 15 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.61566746 |
| 16 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.59332889 |
| 17 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.57133722 |
| 18 | Wnt signaling pathway_Homo sapiens_hsa04310 | 1.52362400 |
| 19 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.49212546 |
| 20 | Circadian entrainment_Homo sapiens_hsa04713 | 1.47636697 |
| 21 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.46511955 |
| 22 | RNA degradation_Homo sapiens_hsa03018 | 1.44909641 |
| 23 | Huntingtons disease_Homo sapiens_hsa05016 | 1.41454493 |
| 24 | Olfactory transduction_Homo sapiens_hsa04740 | 1.39735060 |
| 25 | Circadian rhythm_Homo sapiens_hsa04710 | 1.38140145 |
| 26 | Morphine addiction_Homo sapiens_hsa05032 | 1.37524359 |
| 27 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.35167635 |
| 28 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.33680450 |
| 29 | Proteasome_Homo sapiens_hsa03050 | 1.30119547 |
| 30 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.28711190 |
| 31 | Phototransduction_Homo sapiens_hsa04744 | 1.21824928 |
| 32 | Renin secretion_Homo sapiens_hsa04924 | 1.21453067 |
| 33 | Salivary secretion_Homo sapiens_hsa04970 | 1.19673733 |
| 34 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.17879167 |
| 35 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.16496114 |
| 36 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.11490825 |
| 37 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.10462284 |
| 38 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.07327857 |
| 39 | RNA polymerase_Homo sapiens_hsa03020 | 1.04922673 |
| 40 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.02233160 |
| 41 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.01273533 |
| 42 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.00629596 |
| 43 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.00011840 |
| 44 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.98420802 |
| 45 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.96478417 |
| 46 | Spliceosome_Homo sapiens_hsa03040 | 0.95730858 |
| 47 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.89916589 |
| 48 | Axon guidance_Homo sapiens_hsa04360 | 0.83627936 |
| 49 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.78622510 |
| 50 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.77942780 |
| 51 | GABAergic synapse_Homo sapiens_hsa04727 | 0.77112050 |
| 52 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.76573780 |
| 53 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.76409559 |
| 54 | Protein export_Homo sapiens_hsa03060 | 0.76010144 |
| 55 | Long-term potentiation_Homo sapiens_hsa04720 | 0.75783439 |
| 56 | Basal transcription factors_Homo sapiens_hsa03022 | 0.73313312 |
| 57 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.72570642 |
| 58 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.71783664 |
| 59 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.70268279 |
| 60 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.69692665 |
| 61 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.69400012 |
| 62 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.67480254 |
| 63 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.66357857 |
| 64 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.65614866 |
| 65 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.64355590 |
| 66 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.63939434 |
| 67 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.61225767 |
| 68 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.60185857 |
| 69 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.58582662 |
| 70 | Purine metabolism_Homo sapiens_hsa00230 | 0.58317422 |
| 71 | Long-term depression_Homo sapiens_hsa04730 | 0.55163865 |
| 72 | Melanogenesis_Homo sapiens_hsa04916 | 0.55131626 |
| 73 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.54223055 |
| 74 | Nicotine addiction_Homo sapiens_hsa05033 | 0.53617442 |
| 75 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.53012820 |
| 76 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.50211600 |
| 77 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.48577537 |
| 78 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.45932442 |
| 79 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.45660205 |
| 80 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.44002257 |
| 81 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.41771417 |
| 82 | Melanoma_Homo sapiens_hsa05218 | 0.39897209 |
| 83 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.37457060 |
| 84 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.37427973 |
| 85 | Asthma_Homo sapiens_hsa05310 | 0.36892032 |
| 86 | Adherens junction_Homo sapiens_hsa04520 | 0.36668502 |
| 87 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.35455589 |
| 88 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.35058479 |
| 89 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.33618805 |
| 90 | Platelet activation_Homo sapiens_hsa04611 | 0.32929737 |
| 91 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.32242118 |
| 92 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.30815626 |
| 93 | Retinol metabolism_Homo sapiens_hsa00830 | 0.30457132 |
| 94 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.30303777 |
| 95 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.29551122 |
| 96 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.29277443 |
| 97 | Sulfur relay system_Homo sapiens_hsa04122 | 0.29106128 |
| 98 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.28256818 |
| 99 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.27637037 |
| 100 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.27153532 |

